Swiss Pharmaceutical Industry Loses Ground in Global Innovation Race

Innovation in Switzerland's pharmaceutical industry has declined for the second consecutive year, according to a new study, highlighting the sector's lag behind foreign competitors in digital research and clinical trials. The findings underscore the need for Swiss pharma to invest in digital capabilities to maintain its global edge.